SUMMARY In order to determine whether pregnancy influences the specificity of the fluorescent treponemal antibody absorption (FTA-ABS) and Treponema pallidum haemagglutination assay (TPHA) tests, these tests, together with the quantitative fluorescent treponemal antibody (FTA) and Venereal Disease Research Laboratory (VDRL) tests, were carried out simultaneously on 2000 pregnant women who attended for compulsory prenatal screening. In only one patient (0 05 % of the total investigated) was a positive result to the TPHA test obtained, the specificity of which it was impossible to confirm. The FTA-ABS test gave a weakly reactive result of the borderline type but this was found to be non-specific in only four (0-2 %) patients. The results of our investigations showed that the specificity of the FTA-ABS and the TPHA tests performed on pregnant women did not differ from the specificity of these tests when carried out on other population groups.
Introduction
The problem of the specificity of the fluorescent treponemal antibody absorption (FTA-ABS) test and Treponema pallidum haemagglutination assay (TPHA) during pregnancy is of great practical significance since the FTA-ABS test has been widely used in verification procedures. In applied as a confirmatory test instead of, or in addition to, the FTA-ABS because of the former's sensitivity and specificity. This method has been recommended for verification purposes by several authors, including Johnston (1972) , Kiraly and Prerau (1974), Vaisman et al. (1974) , Rudolph (1976), and Lesinski et al. (1977) . Both the FTA-ABS and TPHA tests are known to possess considerable but not absolute specificity and may give non-specific positive results in comparatively few instances. Some authors (Buchanan and Haserick, 1970; Sparling, 1971; Meyer-Rohn, 1974; Cave and Nikitas, 1976) consider that pregnancy may be a cause of non-specific positive results of the FTA-ABS test. These reports, however, do not give sufficient evidence to show whether instances of non-specific positive FTA-ABS results are indeed noted more frequently in pregnant women than in the general population and, if so, whether this detracts from the value of the FTA-ABS technique in confirming reactive results of cardiolipin tests in pregnant women. In some recent reports (Shore, 1974; Kern, 1975; Meyer-Rohn, 1976) In four patients in whom the FTA-ABS result was of the borderline type both the TPHA and VDRL tests gave negative results and neither clinical evidence nor history indicated previous syphilitic infection. When retested these sera also gave negative FTA-ABS and FTA results. In addition the TPI test carried out on three of these four patients gave negative results.
Discussion
In our study sera from four of the 2000 pregnant women examined gave weakly positive results of the borderline type to the FTA-ABS test but negative results on retesting, and these were probably non-specific. These patients comprised almost 0-2% of the total tested while all the other reactive or weakly reactive results to the FTA-ABS test were confirmed by the other serological tests or by the history and epidemiological evidence.
The problem of the poor reproducibility of the FTA-ABS test indicated by weak fluorescence of the borderline type has been the subject of numerous reports (Burns, 1975; Jaffe, 1975; Dans, 1976; Lesin'ski et al., 1977) . Many of the poorly reproducible FTA-ABS results were found by these authors to be non-specific. Our investigations have shown that non-specific FTA-ABS results do not occur more frequently in women during pregnancy than in other groups.
As the data presented in Table 2 show, in only one of the 2000 pregnant women investigated did the TPHA test give a positive result, the specificity of which it was not possible to confirm; this comprised 0 5% of the total. Our results are in agreement with those of Young et al. (1974) , who obtained identical results in their investigations on 1824 pregnant women, finding only one nonspecific positive TPHA result. West and Pagano (1972) found no non-specific positive results to the TPHA test carried out on 300 pregnant women. Sequeira and Eldrige (1973) In 12 2% of these women antibodies were also detected by the TPHA method. The investigations of Garner et al. (1973) were carried out on persons from areas with a high incidence of tropical diseases.
In the opinion of Kiraly and Prerau (1974) 
